Search research articles
Contact Us
Filters
Showing results (181-190 of 187) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 187 results.
Journal of the American College of Cardiology
|
September 19, 1998
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin
A S Brown, R G Bakker-Arkema, L Yellen, et al.
Genes & Development
|
May 21, 2021
ASCL1 represses a SOX9<sup>+</sup> neural crest stem-like state in small cell lung cancer
Rachelle R Olsen, Abbie S Ireland, David W Kastner, et al.
Oncotarget
|
November 2, 2017
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies
Robert J Cardnell, Lerong Li, Triparna Sen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 6, 2019
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D Chalishazar, Sarah J Wait, Fang Huang, et al.
Cancer Cell
|
June 1, 2020
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S Ireland, Alexi M Micinski, David W Kastner, et al.
Nature Communications
|
August 4, 2019
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
Marcel A Dammert, Johannes Brägelmann, Rachelle R Olsen, et al.
Cancer Cell
|
January 17, 2017
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 187) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 187 results.
Journal of the American College of Cardiology
|
September 19, 1998
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin
A S Brown, R G Bakker-Arkema, L Yellen, et al.
Genes & Development
|
May 21, 2021
ASCL1 represses a SOX9<sup>+</sup> neural crest stem-like state in small cell lung cancer
Rachelle R Olsen, Abbie S Ireland, David W Kastner, et al.
Oncotarget
|
November 2, 2017
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies
Robert J Cardnell, Lerong Li, Triparna Sen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 6, 2019
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D Chalishazar, Sarah J Wait, Fang Huang, et al.
Cancer Cell
|
June 1, 2020
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S Ireland, Alexi M Micinski, David W Kastner, et al.
Nature Communications
|
August 4, 2019
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
Marcel A Dammert, Johannes Brägelmann, Rachelle R Olsen, et al.
Cancer Cell
|
January 17, 2017
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, et al.
Page
of 19